drugset / Trial / NCT06025318

An Evaluation of the Effect of Food on the PK of a Novel PanCytoVir™ Suspension (100mg/ml), in Healthy, Adult Volunteers

NCT06025318

Phase 1 Completed 14 enrolled TrippBio, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This is an open-label, balanced, randomized, two-period, crossover, single dose study to compare the relative bioavailability in normal healthy, adult, human subjects under Fed and Fasting conditions. Subjects will receive a single oral dose of probenecid oral suspension (100 mg/mL) under fed and fasted conditions.

Timeline

Start
2024-09-01
Primary completion
2024-09-30
Completion
2024-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Probenecid Small molecule 1000 mg Oral

Indications

No indication recorded.